Skip to Main Content


Hypertrophic cardiomyopathy (HCM) is usually an autosomal dominant disease of the heart muscle, with an overall prevalence of 1:500 to 1:1000, characterized by a small left ventricular cavity and marked hypertrophy of the myocardium with myofibril disarray.1-8


The basis of HCM has been ascribed to multiple etiologies9,10; however, in 1989, investigators first mapped a genetic mutation for HCM to chromosome 14.11,12 This mutation later was shown to effect the encoding of β-myosin heavy chain protein, which is a major component of the cardiac sarcomere.13,14 Subsequently, hundreds of mutations have been found in HCM patients; most of these mutations involve the myofilaments of the cardiac sarcomere; however, there is increasing awareness of nonsarcomeric mutations as well.15,16 Thus, HCM, in its most common manifestation, is felt to be a disease of the myofilaments, whose alteration in structure and/or function underlies the pathology and pathophysiology in affected individuals.17-27


HCM is a highly heterogeneous disease, with a diverse pathology and clinical course.4-7 Some patients may present with severe limiting symptoms of dyspnea, angina, and syncope, and yet other patients may remain completely asymptomatic throughout life. HCM is the most common cause of sudden cardiac death in young people, including trained athletes.28-34 Yet, the overall prognosis of HCM patients is comparable to that of an age-matched, sex-matched control population.4,35-41


The first anatomic description of HCM was by Teare in 1958,42 when he reported the pathologic findings in eight young patients, seven of whom had died suddenly. He found massive hypertrophy of the ventricular septum with microscopic evidence of myocardial disarray of the individual muscle fibers, which was speculated to be due to either a benign tumor or hamartoma. At the same time, Brock43 reported on patients with functional subvalvular left ventricular outflow tract gradients confirmed by pressure gradients. Braunwald and colleagues, in the 1960s, defined the specific disease process, in which asymmetric septal hypertrophy, myofibril disarray, and a dynamic subvalvular pressure gradient were documented.44,45 This entity was considered to be a primary process with no known cause; however, a genetic connection was suggested when a familial link was shown to be associated with this entity in an autosomal dominant fashion.46


Since these initial descriptions, the disease process has come to be known by many names, including asymmetric septal hypertrophy, idiopathic hypertrophic subaortic stenosis, muscle subaortic stenosis, and hypertrophic obstructive cardiomyopathy. The World Health Organization has designated the term hypertrophic cardiomyopathy (HCM) to describe this unique process of primary muscle hypertrophy, which may exist with or without a dynamic left ventricular outflow tract gradient.47,48


The evolution of echocardiography provided a noninvasive diagnostic tool to identify patients with HCM.49-51 Echocardiography showed that hypertrophy in HCM patients could involve areas other than the ventricular septum and further led to the understanding ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessCardiology Full Site: One-Year Subscription

Connect to the full suite of AccessCardiology content and resources including textbooks such as Hurst's the Heart and Cardiology Clinical Questions, a unique library of multimedia, including heart imaging, an integrated drug database, and more.

$595 USD
Buy Now

Pay Per View: Timed Access to all of AccessCardiology

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.